Extensively Drug-Resistant Typhoid - Are Conjugate Vaccines Arriving Just in Time?

N Engl J Med. 2018 Oct 18;379(16):1493-1495. doi: 10.1056/NEJMp1803926.

Authors

Jason R Andrews¹, Farah N Qamar¹, Richelle C Charles¹, Edward T Ryan¹

Affiliation

¹ From the Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA (J.R.A.); the Department of Pediatric and Child Health, the Aga Khan University, Karachi, Pakistan (F.N.Q.); and the Division of Infectious Diseases, Massachusetts General Hospital (R.C.C., E.T.R.), the Department of Medicine, Harvard Medical School (R.C.C., E.T.R.), and the Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (E.T.R.) - all in Boston.

PMID: 30332569
DOI: 10.1056/NEJMp1803926

No abstract available

Publication types

Historical Article

MeSH terms

Anti-Bacterial Agents / history
Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use*
Asia
Child
Disease Outbreaks / history
Drug Resistance, Multiple, Bacterial / genetics*
Haplotypes
History, 20th Century
History, 21st Century
Humans
Immunization Programs
Pakistan / epidemiology
Salmonella typhi / drug effects
Salmonella typhi / genetics
Typhoid Fever / drug therapy
Typhoid Fever / epidemiology
Typhoid Fever / prevention & control*
Typhoid-Paratyphoid Vaccines*
Vaccines, Conjugate*

Substances

Anti-Bacterial Agents
Typhoid-Paratyphoid Vaccines
Vaccines, Conjugate